A new crop of drug-resistant superbugs is in our midst, and experts believe that they could rival the deadly superbug MRSA. A new report from the Infectious Diseases Society of America says these ...

Dr. Timothy Palzkill, professor of Pharmacology and Chemical Biology and Molecular Virology and Microbiology, and his research team have been studying mechanisms of resistance to the beta-lactam ...

Finding effective new medicines, especially against hard-to-treat Gram-negative bacteria, is critical. Now, a recent discovery might offer hope, thanks to researchers at McMaster University who ...

DURHAM, N.C – A scientific journey decades in the making at Duke University has found a new antibiotic strategy to defeat gram-negative bacteria ... low rates of spontaneous resistance mutations in ...

Researchers say they have discovered a new class of antibiotics ... against bacteria, lariocidin also showed no toxicity to human cells. "Lariocidin has a broad spectrum of action as it is effective ...

More than 4.5 million deaths occurred due to antibiotic resistance in 2019. The World Health Organization (WHO) has designated Gram-negative bacteria as a critical threat because of their ability ...

Recent discoveries are helping scientists face this challenge in innovative ways. Studies have found that nearly a quarter of drugs that aren’t normally prescribed as antibiotics, such as medications ...

which can make organisms resistant to almost all beta-lactam antibiotics. MBL-producing Gram-negative bacteria are among the most challenging infections to control, are on the rise globally ...

Encased in both an inner and outer membrane that antibiotics struggle to cross, Gram-negative bacteria are resistant to most currently available therapies. They are also astonishingly canny for ...

Doripenem, a member of the β-lactam class of antibiotics ... bactericidal activity against gram-positive bacteria; enteric and nonenteric gram-negative bacteria, including extended-spectrum ...

In recent years, colistin has attracted considerable interest as an antibiotic ... and resistance, combination therapy and also its use for the treatment of infections due to MDR Gram-negative ...